Menzies Institute for Medical Research Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01176344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Menzies Research Institute Tasmania

Active Ingredients

Drugs in Phase 3 Trials (1)

vitamin d3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Respiratory Tract Infections (Phase 2)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1